Dabigatran versus warfarin in patients with atrial fibrillation.

Dabigatran versus warfarin in patients with atrial fibrillation.
Nurs Older People. 2017 Jun 30;29(6):11
Authors: Sander R
Abstract
Atrial fibrillation is associated with an increased risk of ischaemic stroke and mortality. Guidelines recommend non-vitamin K antagonist oral anticoagulants, or novel oral anticoagulants, as first choice of drug. While they do not require the meticulous dose adjustments that are required for warfarin, a clinical evaluation of appropriate dose is still necessary. Age and chronic kidney disease in patients with atrial fibrillation increase the risk of bleeding during anti-thrombotic treatment.
PMID: 28664799 [PubMed - in process]

Source: Nursing Older People - June 30, 2017 Category: Nursing Authors: Sander R Tags: Nurs Older People Source Type: research